Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colleen Annesley

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Journal of the National Cancer Institute|July 4, 2024
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortiumEric S Schafer, Teresa Rushing, Kristine R Crews, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyPatrick Brown, Hiroto Inaba, Colleen Annesley, et al.
Nature Reviews. Clinical Oncology|January 26, 2021
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cellsHaneen Shalabi, Juliane Gust, Agne Taraseviciute, et al.
Neurology|September 8, 2025
Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell MalignanciesJennifer L McGuire, Soniya Pinto, Esin Nur Erdogan, et al.
Nature Reviews. Rheumatology|July 2, 2025
CAR T cell therapy for children with rheumatic disease: the time is nowHolly Wobma, Stacy P Ardoin, Challice L Bonifant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2021
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALLRegina M Myers, Agne Taraseviciute, Seth M Steinberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2025
Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyHiroto Inaba, David Teachey, Colleen Annesley, et al.
Blood Advances|April 28, 2022
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cellsAdam J Lamble, Regina M Myers, Agne Taraseviciute, et al.
Nature Medicine|January 8, 2025
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trialNicholas A Vitanza, Rebecca Ronsley, Michelle Choe, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Journal of the National Cancer Institute|July 4, 2024
Optimizing early phase clinical trial washout periods: a report from the Therapeutic Advances in Childhood Leukemia and Lymphoma consortiumEric S Schafer, Teresa Rushing, Kristine R Crews, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|January 8, 2020
Pediatric Acute Lymphoblastic Leukemia, Version 2.2020, NCCN Clinical Practice Guidelines in OncologyPatrick Brown, Hiroto Inaba, Colleen Annesley, et al.
Nature Reviews. Clinical Oncology|January 26, 2021
Beyond the storm - subacute toxicities and late effects in children receiving CAR T cellsHaneen Shalabi, Juliane Gust, Agne Taraseviciute, et al.
Neurology|September 8, 2025
Neuroimaging Findings in Children and Young Adults With Neurotoxicity After CAR T-Cell Therapy for B-Cell MalignanciesJennifer L McGuire, Soniya Pinto, Esin Nur Erdogan, et al.
Nature Reviews. Rheumatology|July 2, 2025
CAR T cell therapy for children with rheumatic disease: the time is nowHolly Wobma, Stacy P Ardoin, Challice L Bonifant, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 12, 2021
Blinatumomab Nonresponse and High-Disease Burden Are Associated With Inferior Outcomes After CD19-CAR for B-ALLRegina M Myers, Agne Taraseviciute, Seth M Steinberg, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 12, 2025
Pediatric Acute Lymphoblastic Leukemia, Version 2.2025, NCCN Clinical Practice Guidelines In OncologyHiroto Inaba, David Teachey, Colleen Annesley, et al.
Blood Advances|April 28, 2022
Preinfusion factors impacting relapse immunophenotype following CD19 CAR T cellsAdam J Lamble, Regina M Myers, Agne Taraseviciute, et al.
Nature Medicine|January 8, 2025
Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trialNicholas A Vitanza, Rebecca Ronsley, Michelle Choe, et al.
Pageof 3